Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Strategy of FK 506 therapy in liver transplant patients: effect of graft function.
Who gains most? A 10-year experience with 611 thoracoscopic talc pleurodeses.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Who gains most? A 10-year experience with 611 thoracoscopic talc pleurodeses.
Who gains most? A 10-year experience with 611 thoracoscopic talc pleurodeses. Ann Thorac Surg. 2007 Jun; 83(6):1940-5.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Aged, 80 and over
Female
Humans
Male
Middle Aged
Pleural Effusion
Pleural Effusion, Malignant
Pleurodesis
Retrospective Studies
Sclerosing Solutions
Survival Analysis
Talc
Thoracoscopy